Literature DB >> 23431824

Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.

Hasan Nazik1, Betigul Ongen, Mehmet Ilktac, Selda Aydin, Nuray Kuvat, Aysegul Sahin, Mucahit Yemisen, Bilgul Mete, Mehmet Sait Durmus, Ilker Inanc Balkan, Ismail Yildiz, Yakup Ergul.   

Abstract

Bacterial isolates producing Class D OXA-48 carbapenemase may be missed in routine laboratory testing, allowing them to spread undetected. The purpose of the present study was to detect bla(OXA-48) among ESBL-producing Klebsiella pneumoniae and Escherichia coli isolates collected from a university hospital, Turkey. Ninety-two ESBL-producing isolates (66 E. coli, 26 K. pneumoniae) were obtained in 2010. Antibiotic susceptibility tests were performed using the disc diffusion method and VITEK 2 system. Carbapenemase activity was screened using modified Hodge test. Beta-lactamase genes were detected by PCR and bla(OXA-48)-positive amplicons were sequenced. Genetic relatedness among K. pneumoniae isolates was investigated by pulsed-field gel-electrophoresis (PFGE). Carbapenemase activity was detected in 1 E. coli and 9 K. pneumoniae isolates and 8 of the K. pneumoniae plus the E. coli isolates were resistant to ertapenem. Three K. pneumoniae and 1 E. coli isolates were resistant to imipenem. All 10 isolates were susceptible to meropenem. bla(OXA-48) was present in all 10 isolates. Additionally, 9 isolates contained at least one beta-lactamase gene, including bla(SHV') bla(CTX-M) and bla(VEB) type. PFGE revealed different karyotypes among 9 K. pneumoniae isolates suggesting that the dissemination of bla(OXA-48) gene was not spread by a single K. pneumoniae clone. Thus OXA-48-producing isolates found in carbapenem-susceptible strains according to CLSI guidelines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23431824

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  6 in total

1.  Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia.

Authors:  Setegn Eshetie; Chandrashekhar Unakal; Aschalew Gelaw; Birhanu Ayelign; Mengistu Endris; Feleke Moges
Journal:  Antimicrob Resist Infect Control       Date:  2015-04-17       Impact factor: 4.887

2.  Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance.

Authors:  Richard R Watkins; Krisztina M Papp-Wallace; Sarah M Drawz; Robert A Bonomo
Journal:  Front Microbiol       Date:  2013-12-24       Impact factor: 5.640

3.  Increased constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. and a decrease in microflora diversity may be indicators of ventilator-associated pneumonia: a prospective study in the respiratory tracts of neonates.

Authors:  Wei Lu; Jialin Yu; Qing Ai; Dong Liu; Chao Song; Luquan Li
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 4.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

5.  Dissemination Pattern of Multidrug Resistant Carbapenemase Producing Klebsiella pneumoniae Isolates Using Pulsed-Field Gel Electrophoresis in Southwestern Iran.

Authors:  Zahra Hashemizadeh; Zahra Hosseinzadeh; Negar Azimzadeh; Mohammad Motamedifar
Journal:  Infect Drug Resist       Date:  2020-03-30       Impact factor: 4.003

6.  Surveillance of Antimicrobial Resistance in Hospital Wastewater: Identification of Carbapenemase-Producing Klebsiella spp.

Authors:  Miguel Galarde-López; Maria Elena Velazquez-Meza; Miriam Bobadilla-Del-Valle; Berta Alicia Carrillo-Quiroz; Patricia Cornejo-Juárez; Alfredo Ponce-de-León; Alejandro Sassoé-González; Celia Mercedes Alpuche-Aranda
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.